Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ret-He level in CKD patients receiving ESA
TCTR20220304001Phase 3Enrolling by invitation
- Sponsor
- Udon Thani Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Iron in iron deficiency anemia (IDA), chronic kidney disease (CKD), end-stage kidney disease (ESKD), sponsored by Udon Thani Hospital. Started Jan 2022; status: enrolling by invitation.
02
Drugs
Iron
03
Conditions
iron deficiency anemia (IDA)chronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on TCTR20220304001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220304001.